States Select Centre's Borrowing Option 1 To Meet GST Shortfall
The Union government said on Saturday that all states and three Union Territories have picked the first of the two options to receive compensation on account of implementation of Goods and Services Tax (GST). Under the plan selected by states, the central government will borrow Rs 1.10 lakh crore from the market, to meet the states' revenue shortfall. The remaining shortfall of Rs 73,000 crore is estimated to be due to the coronavirus pandemic. (Also Read: Centre Transfers First Tranche Of Rs 6,000 Crore In GST Compensation To States)
Jharkhand became the latest state to go for Option 1, the Finance Ministry said in a press release. The state will receive Rs 1,689 crore through a special borrowing window to meet the GST shortfall.
The government said it has set up a special borrowing window for the states and union territories to borrow the amount of shortfall arising out of GST rollout. The window came into operation on October 23, and the government has already borrowed Rs 30,000 crore on behalf of states in five instalments.
The next instalment, of Rs 6,000 crore, will be released to the states and Union Territories on December 7, the ministry said.
Under the GST law, which was implemented in 2017, the states were guaranteed compensation for any loss of revenue in the first five years of the new indirect tax regime. The states were mandated to increase their share of revenues by 14 per cent per year.
Meanwhile, the government's GST collections crossed the Rs 1 lakh crore mark for a second straight month in November, official data released earlier this month showed.Â
The government has said that COVID-19 has severely impacted GST collections this year.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.